Elapegademase-lvlr recalls

The FDA has published 1 recall involving Elapegademase-lvlr since 2026. The latest was reported on 9 Sep 2026. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2026

Last 12 months1reported

Class I00% of total

Ongoing1latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 1

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why elapegademase-lvlr is recalled

Potency & Assay1100%

Companies

Chiesi USA1100%

By year

20261100%

Ongoing elapegademase-lvlr recalls

1 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Revcovi (elapegademase-lvlr) Injection, 2.4mg/ (1.6 mg/mL) recalledRevcovi	Chiesi USA	Potency & Assay	MO, TN

All elapegademase-lvlr recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Revcovi (elapegademase-lvlr) Injection, 2.4mg/ (1.6 mg/mL) recalledRevcovi	Chiesi USA	Potency & Assay	MO, TN

Should you stop taking Elapegademase-lvlr?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.